A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 11.4 EUR 0.88% Market Closed
Market Cap: 96.9m EUR

Apontis Pharma AG
Treasury Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Apontis Pharma AG
Treasury Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Treasury Stock CAGR 3Y CAGR 5Y CAGR 10Y
A
Apontis Pharma AG
XETRA:APPH
Treasury Stock
-€170k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Treasury Stock
-€286k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Apontis Pharma AG
Glance View

Market Cap
95m EUR
Industry
Pharmaceuticals

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

APPH Intrinsic Value
16.11 EUR
Undervaluation 29%
Intrinsic Value
Price
A

See Also

What is Apontis Pharma AG's Treasury Stock?
Treasury Stock
-170k EUR

Based on the financial report for Dec 31, 2023, Apontis Pharma AG's Treasury Stock amounts to -170k EUR.

What is Apontis Pharma AG's Treasury Stock growth rate?
Treasury Stock CAGR 1Y
0%

Over the last year, the Treasury Stock growth was 0%.

Back to Top